Activation of the galanin receptor 2 (GalR2) protects the hippocampus from neuronal damage

Journal of Neurochemistry

Volumn 100, Issue 3, 2007, Pages 780-789

  Elliott Hunt, Caroline R ^a   Pope, Robert J P ^a   Vanderplank, Penny ^a   Wynick, David ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Akt; Extracellular signal regulated kinase; Galanin; Galanin receptor 2; Hippocampus; Neuroprotection

Indexed keywords

ENZYME INHIBITOR; GALANIN; GALANIN RECEPTOR 2; GLUTAMIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE FUNCTION; GENE MUTATION; HIPPOCAMPUS; MOUSE; NERVE CELL CULTURE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN DAMAGE, CHRONIC; CYTOPROTECTION; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GALANIN; GLUTAMIC ACID; HIPPOCAMPUS; MALE; MICE; MICE, KNOCKOUT; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; NEURONS; ORGAN CULTURE TECHNIQUES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, GALANIN, TYPE 2; SIGNAL TRANSDUCTION; UP-REGULATION;

ANIMALIA;

EID: 33846226396     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04239.x     Document Type: Article

References (44)

1. Alessi D. R., Cuenda A., Cohen P., Dudley D. T. and Saltiel A. R. (1995) PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270, 27 489-27 494.
2. Almeida R. D., Manadas B. J., Melo C. V., Gomes J. R., Mendes C. S., Graos M. M., Carvalho R. F., Carvalho A. P. and Duarte C. B. (2005) Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways. Cell Death Differentiation 12, 1329-1343.
3. Bacon A., Holmes F. E., Small C. J., Ghatei M., Mahoney S., Bloom S. R. and Wynick D. (2002) Transgenic over-expression of galanin in injured primary sensory neurons. Neuroreport 13, 2129-2132.
4. Brecht S., Buschmann T., Grimm S., Zimmermann M. and Herdegen T. (1997) Persisting expression of galanin in axotomized mamillary and septal neurons of adult rats labeled for c-Jun and NADPH-diaphorase. Brain Res. Mol. Brain Res. 48, 7-16.
5. Burgevin M. C., Loquet I., Quarteronet D. and Habert-Ortoli E. (1995) Cloning, pharmacological characterization, and anatomical distribution of a rat cDNA encoding for a galanin receptor. J. Mol. Neurosci. 6, 33-41.
6. Chang S. H., Poser S. and Xia Z. (2004) A novel role for serum response factor in neuronal survival. J. Neurosci. 24, 2277-2285.
7. Chan-Palay V. (1988) Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia. J. Comp. Neurol. 273, 543-557.
8. Cortes R., Villar M. J., Verhofstad A. and Hokfelt T. (1990) Effects of central nervous system lesions on the expression of galanin: a comparative in situ hybridization and immunohistochemical study. Proc. Natl Acad. Sci. USA 87, 7742-7746.
9. Culmsee C., Gerling N., Lehmann M., Nikolova-Karakashian M., Prehn J. H., Mattson M. P. and Krieglstein J. (2002) Nerve growth factor survival signaling in cultured hippocampal neurons is mediated through TrkA and requires the common neurotrophin receptor P75. Neuroscience 115, 1089-1108.
10. Ding X., MacTavish D., Kar S. and Jhamandas J. H. (2006) Galanin attenuates beta-amyloid (Abeta) toxicity in rat cholinergic basal forebrain neurons. Neurobiol. Dis. 21, 413-420.
11. Elliott-Hunt C. R., Kazlauskaite J., Wilde G. J., Grammatopoulos D. K. and Hillhouse E. W. (2002) Potential signalling pathways underlying corticotrophin-releasing hormone-mediated neuroprotection from excitotoxicity in rat hippocampus. J. Neurochem. 80, 416-425.
12. Elliott-Hunt C. R., Marsh B., Bacon A., Pope R., Vanderplank P. and Wynick D. (2004) Galanin acts as a neuroprotective factor to the hippocampus. Proc. Natl Acad. Sci. USA 101, 5105-5110.
13. Fathi Z., Cunningham A. M., Iben L. G., Battaglino P. B., Ward S. A., Nichol K. A., Pine K. A., Wang J. C., Goldstein M. E. and lismaa T. P., (1997) e. al.Cloning, pharmacological characterisation and distribution of a novel galanin receptor. Mol. Brain Res. 51, 49-59.
14. Fisone G., Wu C. F., Consolo S., Nordstrom O., Brynne N., Bartfai T., Melander T. and Hokfelt T. (1987) Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: histochemical, autoradiographic, in vivo, and in vitro studies. Proc. Natl Acad. Sci. USA 84, 7339-7343.
15. Gary D. S., Milhavet O., Camandola S. and Mattson M. P. (2003) Essential role for integrin linked kinase in Akt-mediated integrin survival signaling in hippocampal neurons. J. Neurochem. 84, 878-890.
16. Habert Ortoli E., Amiranoff B., Loquet I., Laburthe M. and Mayaux J. F. (1994) Molecular cloning of a functional human galanin receptor. Proc. Natl Acad. Sci. USA 91, 9780-9783.
17. Hobson S. A., Holmes F. E., Kerr N. C. H., Pope R. J. and Wynick D. (2006) Mice deficient for galanin receptor 2 have decreased neurite outgrowth from adult sensory neurons and impaired pain-like behaviour. J. Neurochem. 99, 1000-1010.
18. Holmes F. E., Mahoney S., KingV. R., Bacon A., Kerr N. C. H., PachnisV., Curtis R., Priestley J. V. and Wynick D. (2000) Targeted disruption of the galanin gene reduces the number of sensory neurons and their regenerative capacity. Proc. Natl Acad. Sci. USA 97, 11 563-11 568.
19. Howard A. D., Tan C., Shiao L. L., Palyha O. C., McKee K. K., Weinberg D. H., Feighner S. D., Cascieri M. A., Smith R. G. and Van der Ploeg L. H., (1997) e. al.Molecular cloning and characterisation of a new receptor for galanin. FEBS Lett. 405, 285-290.
20. Kolakowski L. F., Oneill G. P., Howard A. D. et al. (1998) Molecular characterization and expression of cloned human galanin receptors GALR2 and GALR3. J. Neurochem. 71, 2239-2251.
21. Liu H. X., Brumovsky P., Schmidt R., Brown W., Payza K., Hodzic L., Pou C., Godbout C. and Hokfelt T. (2001) Receptor subtype-specific pronociceptive and analgesic actions of galanin in the spinal cord: selective actions via GalR1 and GalR2 receptors. Proc. Natl Acad. Sci. USA 98, 9960-9964.
22. Lu X., Lundstrom L. and Bartfai T. (2005a) Galanin (2-11) binds to GalR3 in transfected cell lines: limitations for pharmacological definition of receptor subtypes. Neuropeptides 39, 165-167.
23. Lu X., Mazarati A., Sanna P., Shinmei S. and Bartfai T. (2005b) Distribution and differential regulation of galanin receptor subtypes in rat brain: effects of seizure activity. Neuropeptides 39, 147-152.
24. Maher P. (2001) How protein kinase C activation protects nerve cells from oxidative stress-induced cell death. J. Neurosci. 21, 2929-2938.
25. Mahoney S. A., Hosking R., Farrant S., Holmes F. E., Jacoby A. S., Shine J., Iismaa T. P., Scott M. K., Schmidt R. and Wynick D. (2003) The second galanin receptor GalR2 plays a key role in neurite outgrowth from adult sensory neurons. J. Neurosci. 23, 416-421.
26. Mennicken F., Hoffert C., Pelletier M., Ahmad S. and O'Donnell D. (2002) Restricted distribution of galanin receptor 3 (GalR3) mRNA in the adult rat central nervous system. J. Chem. Neuroanat. 24, 257-268.
27. Mize A. L., Shapiro R. A. and Dorsa D. M. (2003) Estrogen receptor-mediated neuroprotection from oxidative stress requires activation of the mitogen-activated protein kinase pathway. Endocrinology 144, 306-312.
28. O'Donnell. D., Ahmad. S., Wahlestedt. C. and Walker. P. (1999) Expression of the novel galanin receptor subtype GALR2 in the adult rat CNS: distinct distribution from GALR1. J. Comparative Neurol. 409, 469-481.
29. O'Meara G., Coumis U., Ma S. Y. et al. (2000) Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons. Proc. Natl Acad. Sci. USA 97, 11 569-11 574.
30. Ozawa H., Shioda S., Dohi K., Matsumoto H., Mizushima H., Zhou C. J., Funahashi H., Nakai Y., Nakajo S. and Matsumoto K. (1999) Delayed neuronal cell death in the rat hippocampus is mediated by the mitogen-activated protein kinase signal transduction pathway. Neurosci. Lett. 262, 57-60.
31. Pieribone V. A., Xu Z. Q., Zhang X., Grillner S., Bartfai T. and Hokfelt T. (1995) Galanin induces a hyperpolarization of norepinephrine-containing locus coeruleus neurons in the brainstem slice. Neuroscience 64, 861-874.
32. Pirondi S., Fernandez M., Schmidt R., Hokfelt T., Giardino L. and Calza L. (2005) The galanin-R2 agonist AR-M1896 reduces glutamate toxicity in primary neural hippocampal cells. J. Neurochem. 95, 821-833.
33. Rao V. L. R., Bowen K. K., Dhodda V. K., Song G. Q., Franklin J. L., Gavva N. R. and Dempsey R. J. (2002) Gene expression analysis of spontaneously hypertensive rat cerebral cortex following transient focal cerebral ischemia. J. Neurochem. 83, 1072-1086.
34. Sato S., Fujita N. and Tsuruo T. (2004) Involvement of 3-phosphoinositide-dependent protein kinase-1 in the MEK/MAPK signal transduction pathway. J. Biol. Chem. 279, 33 759-33 767.
35. Swanson C. J., Blackburn T. P., Zhang X. et al. (2005) Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299. Proc. Natl Acad. Sci. USA 102, 17 489-17 494.
36. Tatemoto K., Rokaeus A., Jornvall H., McDonald T. J. and Mutt V. (1983) Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett. 164, 124-128.
37. Vlahos C. J., Matter W. F., Hui K. Y. and Brown R. F. (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1- benzopyran-4-one (LY294002). J. Biol. Chem. 269, 5241-5248.
38. Wang S. K., He C. G., Hashemi T. and Bayne M. (1997) Cloning and expressional characterization of a novel galanin receptor - Identification of different pharmacophores within galanin for the three galanin receptor subtypes. J. Biol. Chem. 272, 31 949-31 952.
39. Wang S., Hashemi T., Fried S., Clemmons A. L. and Hawes B. E. (1998) Differential intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes. Biochemistry 37, 6711-6717.
40. Wittau N., Grosse R., Kalkbrenner F., Gohla A., Schultz G. and Gudermann T. (2000) The galanin receptor type 2 initiates multiple signaling pathways in small cell lung cancer cells by coupling to G (q), G (i) and G (12) proteins. Oncogene 19, 4199-4209.
41. Wynick D., Small C. J., Bacon A. et al. (1998) Galanin regulates prolactin release and lactotroph proliferation. Proc. Natl Acad. Sci. USA 95, 12 671-12 676.
42. Zambrowicz B. P., Abuin A., Ramirez-Solis R. et al. (2003) Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention. Proc. Natl Acad. Sci. USA 100, 14 109-14 114.
43. Zheng W. H. and Quirion R. (2004) Comparative signaling pathways of insulin-like growth factor-1 and brain-derived neurotrophic factor in hippocampal neurons and the role of the PI3 kinase pathway in cell survival. J. Neurochem. 89, 844-852.
44. Zini S., Roisin M. P., Langel U., Bartfai T. and Ben-Ari Y. (1993) Galanin reduces release of endogenous excitatory amino acids in the rat hippocampus. Eur. J. Pharmacol. 245, 1-7.